Lords peers vow to fight law on assisted dying as they warn it may not 'see the light of day' despite narrow backing by MPs
Campaigners last night vowed to fight the assisted dying Bill in the Lords after MPs moved to legalise it in a historic vote.
In a sign of the concern about the Bill, it passed through the Commons by just 23 votes yesterday – 32 fewer than when MPs backed it in principle in November.
MPs questioned whether there was a clear mandate to introduce one of the most significant social changes in Britain for decades.
And peers vowed there would be an 'attritional' fight when the legislation, decried as a 'bad Bill' after multiple amendments were laid and safeguards stripped out, moves to the House of Lords. One warned that it may not 'see the light of day'.
The Commons voted 314 to 291 in favour of allowing terminally ill people to end their lives with the help of the State, meaning that when abstentions are included, a majority of MPs did not back the Bill.
Sir Keir Starmer and Chancellor Rachel Reeves voted in favour, while opponents included Health Secretary Wes Streeting, Deputy Prime Minister Angela Rayner and Tory leader Kemi Badenoch.
Labour MP Kim Leadbeater's Terminally Ill Adults (End of Life) Bill will undergo further scrutiny in the Lords, but peers said there was 'no constitutional reason' why it could not be amended significantly or even thrown out by the Upper House.
Following an emotional debate in the Commons, Ms Leadbeater described the vote as a 'huge moment in time' and said it would 'correct the profound injustices of the status quo and offer a compassionate and safe choice to terminally ill people'.
TV presenter Dame Esther Rantzen, who has terminal lung cancer and led the campaign for assisted dying, said: 'This will make a huge positive difference, protecting millions of terminally ill patients and their families from the agony and loss of dignity created by a bad death.'
But leading opponent Danny Kruger – whose mother, Dame Prue Leith, was outside Westminster campaigning in favour of the legalisation yesterday – said the vote showed support 'is ebbing away very fast'.
The Tory MP added: 'I'm hopeful now, inspired by that debate and by the falling away of support for the Bill, that the Lords will feel they have a real job to do – to examine closely how the Bill will operate and to introduce their own amendments to make it safer, or to reject the Bill altogether.'
Tory peer and former Cabinet minister Mark Harper said it was possible the Bill may not 'see the light of day'. Lord Harper, who is against assisted dying, told the Mail: 'It's not a government Bill and it wasn't in anybody's manifesto, so there is no constitutional reason why the Lords shouldn't do its job properly and amend the Bill considerably if required.'
Baroness Tanni Grey-Thompson – a leading opponent of assisted dying – said disabled people were 'absolutely terrified' about the Bill as she vowed to add significant safeguards in the Lords.
It is thought it will take four years to implement the Bill should it clear the remaining stages this year and receive royal assent, meaning the first assisted death in Britain would take place by 2029.
This would mark the first time the State sanctioned a death since capital punishment was abolished in 1965, and the Government forecasts that up to 4,500 people could end their lives early each year within a decade.
Under the legislation terminally ill people in England and Wales diagnosed with less than six months to live will be allowed to seek medical help to die
Opening the debate in the Commons, Spen Valley MP Ms Leadbeater said her Bill proposed a 'robust process that goes further than any other piece of legislation in the world'. She added:
'Giving dying people choice about how they die is about compassion, control, dignity and bodily autonomy. Surely we should all have the right to decide what happens to our bodies and decide when enough is enough.'
But after the vote, Tory MP Greg Smith said: 'It is not too late for us to step back from the brink and pull the plug on this Bill, which now lacks majority support in the Commons. I trust the House of Lords to scrutinise the Bill in depth and hope it will never reach royal assent.'
Catherine Robinson, from campaign group Right To Life UK, said: 'The Bill leaves the Commons lacking a majority, with fewer than half of all MPs voting for it at its final stage. We will be fighting this Bill at every stage in the House of Lords, where we are confident it can be overturned given its continued loss of support.'
The assisted dying Bill that returned to the Commons yesterday was significantly changed from the one presented to MPs at the second reading vote in November.
Among radical amendments were the removal of the High Court safeguard – with a senior judge replaced by so-called 'suicide panels' made up of a lawyer, psychiatrist and social worker.
The proposed legislation will allow terminally ill adults in England and Wales with fewer than six months to live to apply for an assisted death. Subject to approval by two doctors and an 'expert panel', the terminally ill person would take an approved substance, provided by a doctor but administered only by the person themselves.
Religious groups expressed horror at the Bill's passing.
Bishop of London the Rt Rev Sarah Mullally, who sits in the House of Lords, said her peers 'must oppose' the Bill due to the 'mounting evidence that it is unworkable and unsafe'.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
The Independent
5 minutes ago
- The Independent
Weight loss pill shows promise in new trial
A new weight loss medication, which can be offered by injection or tablet, can help patients lose a significant amount weight, studies suggest. An early study have found that people who received higher doses of amycretin as a weekly jab lost 24.3% of their body weight after 36 weeks of treatment. And initial trials assessing a tablet form of the drug also showed promising results, with patients taking daily tablets losing an average of 13.1% of their body weight after 12 weeks. Weight loss jabs have been hailed as transformative by NHS leaders. But injections come with additional work for over-stretched health services so tablet forms of medication may offer a new hope for the millions of people looking to lose weight. It has been estimated that around 1.5 million Britons are having weight loss jabs, which have been either prescribed through specialist weight loss services or private prescriptions. GPs will be able to dish out that jabs from next week. Amycretin, made by Novo Nordisk, helps to control blood sugar and appetite by targeting two specific receptors in the body – GLP-1 and the amylin receptor. An early trial in 125 adults testing weekly injections of amycretin, which has been published in The Lancet, found that those taking the highest dosage (60mg) lost 24.3% after 36 weeks of treatment. It also showed signs in improving blood sugar levels. Side effects included nausea and vomiting and were mostly mild to moderate and resolved by the end of treatment. 'These phase 1b/2a data support the potential of once-weekly subcutaneous amycretin as a therapeutic for people living with overweight or obesity,' the authors wrote. 'Amycretin appeared safe and tolerable, and there were significant reductions in body weight after 36 weeks of treatment.' The second early trial, published in the same journal, assessed amycretin in tablet form in 144 people over 12 weeks. There were mild to moderate side effects including loss of appetite, nausea and vomiting. Researchers found that people taking the highest dose of 100mg per day, lost 13.1% of their body weight over four months. The authors wrote: 'Amycretin effectively lowered body weight and improved metabolic and glycaemic parameters in people with overweight or obesity. 'Longer studies with more participants are warranted for evaluation of the safety and efficacy of amycretin in individuals living with obesity and type 2 diabetes, and to optimise the dosing regimen.' The studies were also presented at the American Diabetes Association's Scientific Sessions in Chicago, in the US. It comes as a separate study, which was published at the same meeting, examined the effects of weight loss jab Wegovy at higher doses. Researchers found that giving patients 7.2mg of Wegovy, also known as semaglutide, once a week led to an average weight loss of 20.7%, with a third of participants losing 25% or more of their body weight after 72 weeks.
Daily Mail
16 minutes ago
- Daily Mail
ANDREW NEIL: No future UK government has a hope of making things better if it can't reform our incompetent Left-wing, WFH civil service
Former Tory Cabinet minister-turned-magazine editor, Michael Gove, this week revealed that, as Education Secretary, he had to overrule civil servants who wanted to suppress newspaper revelations about in Rotherham. The local council requested the government join it in legal action to prevent The Times from publishing details of its ground-breaking investigation into the scandal. Some senior civil servants in his department advised Gove to join in this bid to muzzle the press.
Daily Mail
27 minutes ago
- Daily Mail
Erectile dysfunction drug Viagra has surprise new health benefit, scientists find - offering new hope to 3million ageing Britons
A surprising new health benefit has emerged from the sex drug Viagra - which means three million ageing Britons can now also enjoy a harder skull. The little blue tablet was found to increase the production of vital bone cells, preventing back pain and fractures in old age. Sildenafil - also known as Viagra - can help human stem cells transform into osteoblasts which help the human skeleton regenerate as it is completely replaced roughly once every 10 years. As humans get older, they lose more bone than is built, increasing the risk of breaks or osteoporosis, which makes bones brittle and painful. Follow-up tests on mice by Peking University also suggested a prevention of bone loss. Dr Menglong Hu and Dr Likun Wu told MailOnline: 'Our findings offer new insights into the physiological effects of the medicine. 'Sildenafil enhanced stem cell osteogenic differentiation and inhibited bone loss — it may usefully treat osteoporosis.' Viagra was invented as a heart drug in the 1980s before being found to help with erectile dysfunction. Some studies suggest it may also help reduce the risk of dementia. However, the have been cautions over the years that the drug could have some negative side effects, in particular if taken too much. A large quantity of the drug could result in a painful, 'uncomfortably and disproportionately large erection' called a priapism which could go on for hours. Some experts also found regularly taking the common drug may raise the risk of three serious eye conditions. Common side effects may include headaches, hot flushes, nausea, indigestion, dizziness and a stuffy nose. Nearly half of men between the ages of 40 and 70 suffer from erectile dysfunction in the UK - this is more than 4.5 million people. Though, reports suggest Viagra is now even becoming increasingly popular with younger individuals in their 20s and 30s. Last year, it emerged Viagra may help prevent dementia by boosting blood flow in the brain. 'This is the first trial to show that sildenafil gets into the blood vessels in the brain in people with this condition, improving blood flow and how responsive these blood vessels are,'Dr Alastair Webb, a neurologist and study author at Oxford University said.
